HUTCHMED (China) Limited

As of December 31, 2025, HUTCHMED (China) Limited carries a market capitalization of 1.89B, placing it among publicly traded companies globally. Its enterprise value stands at 822.42M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

HUTCHMED (China) Limited's next confirmed earnings release is scheduled for March 4, 2027.

As of December 31, 2025, HUTCHMED (China) Limited has 859.74M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, HUTCHMED (China) Limited maintains a current ratio of 4.96, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, HUTCHMED (China) Limited's stock has declined approximately 6.06% over the past 52 weeks. The 50-day moving average sits at 2.35, while the 200-day moving average is 2.27.

As of December 31, 2025, HUTCHMED (China) Limited holds 1.16B in cash and equivalents against 83.32M in total debt, resulting in a net debt position of 18.58M. Total book value stands at 1.05B, with working capital of 1.07B providing operational flexibility.